On march 25, 2024, Q32 Bio Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.77 USD | -3.97% |
|
-18.80% | +34.96% |
06-17 | Guggenheim Initiates Q32 Bio at Buy With $100 Price Target | MT |
05-21 | Leerink Partners Starts Q32 Bio With Outperform Rating | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
42.19 USD | -0.09% | +3.38% | 85.52B | ||
14.77 USD | -3.97% | -18.80% | 176M | ||
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.96% | 176M | |
+16.45% | 122B | |
+21.96% | 116B | |
+24.08% | 27.03B | |
-20.05% | 20.36B | |
-16.40% | 16.43B | |
-16.28% | 15.91B | |
-44.35% | 15.6B | |
+63.91% | 14.94B | |
+2.52% | 13.59B |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- Q32 Bio Inc. announced that it has received $42 million in funding from a group of investors